Jennifer S Herrick
Overview
Explore the profile of Jennifer S Herrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
2185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
King J, Sakhuja S, Derington C, Kolm P, Herrick J, Berchie R, et al.
J Am Heart Assoc
. 2024 Sep;
13(18):e034515.
PMID: 39248269
No abstract available.
2.
King J, Berchie R, Derington C, Marcum Z, Scharfstein D, Greene T, et al.
J Am Heart Assoc
. 2023 Aug;
12(17):e030311.
PMID: 37646208
BACKGROUND Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) block distinct components of the renin-angiotensin system. Whether this translates into differential effects on cardiovascular disease events remains unclear....
3.
Myers J, Stoffel J, Elliott S, Welk B, Herrick J, Lenherr S
J Urol
. 2023 Jul;
210(4):659-669.
PMID: 37395612
Purpose: We sought to characterize sex-stratified differences in bladder management and bladder symptoms and satisfaction after spinal cord injury. Materials And Methods: This study was a prospective, cross-sectional, observational study;...
4.
Derington C, Bress A, Berchie R, Herrick J, Shen J, Ying J, et al.
Am J Hypertens
. 2023 Jun;
36(9):498-508.
PMID: 37378472
Background: The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated an intensive (<120 mm Hg) vs. standard (<140 mm Hg) systolic blood pressure (SBP) goal lowered cardiovascular disease (CVD) risk. Estimating...
5.
King J, Derington C, Herrick J, Jacobs J, Zheutlin A, Conroy M, et al.
Hypertension
. 2023 Jun;
80(8):1749-1758.
PMID: 37288570
Background: Single-pill combination (SPC) antihypertensive products improve blood pressure control and medication adherence among patients with hypertension. It is unknown to what degree commercially available SPC products could be used...
6.
Ghazi L, Shen J, Ying J, Derington C, Cohen J, Marcum Z, et al.
JAMA Netw Open
. 2023 May;
6(5):e2314443.
PMID: 37204788
Importance: Intensive vs standard treatment to lower systolic blood pressure (SBP) reduces risk of mild cognitive impairment (MCI) or dementia; however, the magnitude of cognitive benefit likely varies among patients....
7.
Zheutlin A, Addo D, Jacobs J, Derington C, Herrick J, Greene T, et al.
Hypertension
. 2023 May;
80(7):1484-1493.
PMID: 37165900
Background: Despite evidence supporting the cardiovascular and cognitive benefits of intensive blood pressure management, older adults have the lowest rates of blood pressure control. We determined the association between age...
8.
Derington C, Bress A, Herrick J, Jacobs J, Zheutlin A, Berchie R, et al.
J Am Heart Assoc
. 2023 May;
12(11):e028573.
PMID: 37158068
Background Fixed-dose combination (FDC) antihypertensive products improve blood pressure control and adherence among patients with hypertension. It is unknown to what degree commercially available FDC products meet the current hypertension...
9.
Jaeger B, Chen L, Foti K, Hardy S, Bress A, Kane S, et al.
Hypertension
. 2023 Apr;
80(6):1311-1320.
PMID: 37082970
Background: Data from the US National Health and Nutrition Examination Survey are freely available and can be analyzed to produce hypertension statistics for the noninstitutionalized US population. The analysis of...
10.
Jacobs J, Addo D, Zheutlin A, Derington C, Essien U, Navar A, et al.
JAMA Cardiol
. 2023 Mar;
8(5):443-452.
PMID: 36947031
Importance: The burden of atherosclerotic cardiovascular disease (ASCVD) in the US is higher among Black and Hispanic vs White adults. Inclusion of race in guidance for statin indication may lead...